Page last updated: 2024-08-24

temoporfin and Bile Duct Cancer

temoporfin has been researched along with Bile Duct Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chen, ZL; Gadoora, MA; Gao, YH; Li, MY; Meharban, F; Nyokong, T; Sajjad, F; Wang, JH; Yan, YJ1
Fabian, J; Herrmann, FC; Langer, K; Mulac, D; Stein, NC1
Berr, F; Denzer, UW; Emmanuel, K; Friesenbichler, P; Kiesslich, T; Lohse, AW; Neureiter, D; Puespoek, A; Wagner, A; Wolkersdörfer, GW1
Betz, CS; Göke, B; Kniebühler, G; Pongratz, T; Schirra, J; Sroka, R; Stepp, H1
Ortner, MA1
Ayaru, L; Bown, SG; Hatfield, AR; Mosse, A; Pereira, SP; Rogowska, A1

Reviews

1 review(s) available for temoporfin and Bile Duct Cancer

ArticleYear
Photodynamic therapy for cholangiocarcinoma: overview and new developments.
    Current opinion in gastroenterology, 2009, Volume: 25, Issue:5

    Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Hematoporphyrins; Humans; Interleukin-6; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Stents

2009

Trials

2 trial(s) available for temoporfin and Bile Duct Cancer

ArticleYear
Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.
    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2013, Volume: 12, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents

2013
Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
    Photodiagnosis and photodynamic therapy, 2013, Volume: 10, Issue:3

    Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Dose-Response Relationship, Drug; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Stents; Survival Rate; Treatment Outcome

2013

Other Studies

3 other study(ies) available for temoporfin and Bile Duct Cancer

ArticleYear
Synthesis and pharmacological evaluation of chlorin derivatives for photodynamic therapy of cholangiocarcinoma.
    European journal of medicinal chemistry, 2020, Mar-01, Volume: 189

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Female; Humans; Light; Male; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Necrosis; Photochemotherapy; Photosensitizing Agents; Porphyrins; Xenograft Model Antitumor Assays

2020
Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system.
    International journal of pharmaceutics, 2020, May-30, Volume: 582

    Topics: Bile Duct Neoplasms; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Humans; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Serum Albumin, Bovine; Solubility

2020
Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin.
    European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:6

    Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Stents; Survival Analysis; Treatment Outcome

2007